These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Treatment of intraocular fibrin formation with tissue plasminogen activator after vitrectomy]. Zhao P; Wang W Zhonghua Yan Ke Za Zhi; 1995 Jul; 31(4):255-8. PubMed ID: 8745515 [TBL] [Abstract][Full Text] [Related]
30. Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery. Wedrich A; Menapace R; Ries E; Polzer I J Cataract Refract Surg; 1997; 23(6):873-7. PubMed ID: 9292671 [TBL] [Abstract][Full Text] [Related]
31. The use of tissue plasminogen activator in postvitrectomy cases. Koutsandrea C; Apostolopoulos M; Theodossiadis P Int Ophthalmol; 1993 Apr; 17(2):95-100. PubMed ID: 8407122 [TBL] [Abstract][Full Text] [Related]
32. The lowest effective dose of tissue plasminogen activator for fibrinolysis of postvitrectomy fibrin. Boldt HC; Abrams GW; Murray TG; Han DP; Mieler WF Retina; 1992; 12(3 Suppl):S75-9. PubMed ID: 1455089 [TBL] [Abstract][Full Text] [Related]
33. [Therapeutic and prophylactic application of TPA (recombinant tissue plasminogen activator) into the anterior chamber of the eye]. Rehfeldt K; Höh H Ophthalmologe; 1999 Sep; 96(9):587-93. PubMed ID: 10501987 [TBL] [Abstract][Full Text] [Related]
34. Three cases of corneal perforation caused by noncontact tonometry. Kim EC; Kim MS Cornea; 2008 Dec; 27(10):1191-4. PubMed ID: 19034141 [TBL] [Abstract][Full Text] [Related]
36. Tissue plasminogen activator in the treatment of vitreoretinal diseases. Kamei M; Estafanous M; Lewis H Semin Ophthalmol; 2000 Mar; 15(1):44-50. PubMed ID: 10749314 [TBL] [Abstract][Full Text] [Related]
37. Topical treatment of postvitrectomy fibrin formation with tissue plasminogen activator. Cellini M; Baldi A; Possati GL Int Ophthalmol; 1994-1995; 18(6):351-3. PubMed ID: 7642335 [TBL] [Abstract][Full Text] [Related]